SMTL ID : 5gix.1 (1 other biounit)

Human serum albumin-Palmitic acid-Fe(Hn3piT)Cl2

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.80 Å

Oligo State

monomer

Ligands

1 x 6WF: 14-piperidin-1-yl-11-oxa-13$l^{3}-thia-15,16$l^{4}-diaza-12$l^{3}-ferratetracyclo[8.7.0.0^{2,7}.0^{12,16}]heptadeca-1(10),2(7),3,5,8,13,16-heptaene(Covalent)

6WF.1: 15 residues within 4Å: Chain A: Y.148, Q.194, K.197, C.198, L.236, H.240, C.243, C.244, C.251, R.255, L.258, I.262, S.285, I.288, A.289 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:Y.148, A:Q.194, A:L.236, A:L.258, A:I.288, A:A.289 Hydrogen bonds: A:R.255, A:R.255 Metal complexes: A:H.240

6 x PLM: PALMITIC ACID(Covalent)(Non-covalent)

PLM.2: 8 residues within 4Å: Chain A: R.115, L.133, Y.136, L.137, A.156, Y.159, L.180, R.184 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:R.115, A:Y.136, A:Y.136, A:Y.136, A:A.156, A:Y.159, A:Y.159 Salt bridges: A:R.115, A:R.184 PLM.3: 16 residues within 4Å: Chain A: R.8, L.12, L.20, V.44, L.64, L.67, F.68, Y.148, P.150, L.248, L.249, A.252, R.255, L.281, L.282, S.285 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:L.12, A:L.20, A:V.44, A:L.64, A:L.67, A:F.68, A:P.150, A:L.248, A:A.252, A:L.282 Hydrogen bonds: A:Y.148, A:L.281, A:S.285 Salt bridges: A:R.255 PLM.4: 10 residues within 4Å: Chain A: S.340, V.342, R.346, L.385, N.389, M.444, E.448, L.451, R.483 Ligands: PLM.5 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:V.342, A:L.385, A:L.385, A:N.389, A:E.448 Hydrogen bonds: A:S.340, A:S.340 Salt bridges: A:R.346, A:R.483 PLM.5: 11 residues within 4Å: Chain A: R.408, Y.409, V.416, L.455, L.458, H.462, V.471, R.483, F.486, S.487 Ligands: PLM.4 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:Y.409, A:Y.409, A:Y.409, A:V.416, A:L.455, A:L.458, A:L.458, A:L.458, A:H.462, A:F.486, A:F.486 Hydrogen bonds: A:S.487 Salt bridges: A:R.408, A:K.412 PLM.6: 12 residues within 4Å: Chain A: Y.399, F.500, F.505, K.523, A.526, L.527, L.530, H.533, V.545, M.546, F.549, S.577 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:F.500, A:A.526, A:L.527, A:L.530, A:V.545, A:M.546, A:F.549, A:F.549 Hydrogen bonds: A:Y.399 Salt bridges: A:K.523 PLM.7: 10 residues within 4Å: Chain A: R.207, A.208, K.210, A.211, V.214, D.322, L.325, G.326, K.349, E.352 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:A.208, A:K.210, A:L.325 Salt bridges: A:K.349

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Qi, J. et al., Developing Anticancer Ferric Prodrugs Based on the N-Donor Residues of Human Serum Albumin Carrier IIA Subdomain. J. Med. Chem. (2016)

Release Date

2017-07-19

Peptides

Serum albumin: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Serum albumin

Related Entries With Identical Sequence